For InvestorsAbout AuxiliumTESTIM®Product PipelineNews & InformationFor InvestorsCareers
For Investors

2008 Annual Report to Shareholders | 2009 Proxy Statement

Auxilium is dedicated to keeping our investors informed about the latest corporate information. To this end, this section is designed to provide comprehensive, up-to-date, public information.

Webcast ImageWebcast
Q4 2009 Auxilium Pharmaceuticals, Inc. Earnings Conference Call (Live)
Feb 17, 2010 at 10:00 a.m. ET
Webcast ImageWebcast
Auxilium Pharmaceuticals, Inc. Investor call (Replay)
Feb 3, 2010 at 8:30 a.m. ET
Corporate Profile
Auxilium Pharmaceuticals (NASDAQ: AUXL) was founded in 1999 to develop and market pharmaceutical products that focus on urology and sexual health. While we remain dedicated to this founding principle, Auxilium’s mission has expanded to include the development and marketing of novel treatment options for many of society’s unmet medical needs.

To support this mission of providing innovati... More >>

Stock Quote
AUXL (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$30.83
Change (%) Stock is Down 0.21 (0.68%)
Volume471,200
Data as of Feb 8, 2010 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent News
RSS Feeds RSS
|
More >>
DateTitle 
Feb 4, 2010Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Results and Conduct Conference Call on Wednesday, February 17, 2010Printer Friendly Version
Feb 2, 2010Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX(TM) for the Treatment of Dupuytren's ContracturePrinter Friendly Version
Jan 21, 2010Pfizer and Auxilium Announce Commencement of European Regulatory Review of XIAFLEXTM for the Treatment of Dupuytren's ContracturePrinter Friendly Version
Dec 31, 2009Auxilium Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare ConferencePrinter Friendly Version
Upcoming EventsMore >>
DateTitle
Feb 17, 2010 10:00 a.m. ET
Q4 2009 Auxilium Pharmaceuticals, Inc. Earnings Conference Call
Featured Report
There are currently no items available.
Receive E-mail AlertsE-mail Alert Icon
To recieve email alerts about updates to Auxilium Pharmaceuticals, Inc. information, please enter your email address.
 
Copyright © 2008 MarketWatch, Inc. All rights reserved. Please see our Terms of Use.
Designed and powered by Dow Jones Client Solutions
Intraday data provided by Interactive Data Real Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical and current end-of-day data provided by Interactive Data Pricing and Reference Data.